These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2074518)

  • 21. Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.
    Golijanin D; Sherman Y; Shapiro A; Pode D
    Urology; 1995 Aug; 46(2):173-7. PubMed ID: 7624989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic cytology of urinary tract carcinoma. A review of experience with spontaneous and carcinogen induced tumors in man.
    Melamed MR
    Eur J Cancer (1965); 1972 Jun; 8(3):287-92. PubMed ID: 5074773
    [No Abstract]   [Full Text] [Related]  

  • 23. Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan.
    Chen HI; Liou SH; Loh CH; Uang SN; Yu YC; Shih TS
    Urology; 2005 Aug; 66(2):305-10. PubMed ID: 16098360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
    Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
    Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of urinary nuclear matrix protein-22 and bladder tumour antigen tests with voided urinary cytology in detecting and following bladder cancer: the prognostic value of false-positive results.
    Poulakis V; Witzsch U; De Vries R; Altmannsberger HM; Manyak MJ; Becht E
    BJU Int; 2001 Nov; 88(7):692-701. PubMed ID: 11890239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary report of the clinical performance of a new urinary bladder cancer antigen test: comparison to voided urine cytology in the detection of transitional cell carcinoma of the bladder.
    Sumi S; Arai K; Kitahara S; Yoshida KI
    Clin Chim Acta; 2000 Jun; 296(1-2):111-20. PubMed ID: 10807975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of urinary markers for the detection and prognosis of bladder carcinoma: a comparison of immunocytology with monoclonal antibodies against Lewis X and 486p3/12 with the BTA STAT and NMP22 tests.
    Friedrich MG; Hellstern A; Hautmann SH; Graefen M; Conrad S; Huland E; Huland H
    J Urol; 2002 Aug; 168(2):470-4. PubMed ID: 12131290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
    Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
    Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
    Chang SS; Reuter VE; Heston WD; Bander NH; Grauer LS; Gaudin PB
    Cancer Res; 1999 Jul; 59(13):3192-8. PubMed ID: 10397265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against transitional cell carcinoma for detection of malignant urothelial cells in bladder washing.
    Chopin DK; deKernion JB; Rosenthal DL; Fahey JL
    J Urol; 1985 Aug; 134(2):260-5. PubMed ID: 3894692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
    Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
    Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive diagnosis of bladder carcinoma by enzyme-linked immunosorbent assay detection of CD44 isoforms in exfoliated urothelia.
    Woodman AC; Goodison S; Drake M; Noble J; Tarin D
    Clin Cancer Res; 2000 Jun; 6(6):2381-92. PubMed ID: 10873090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
    Tanaka K; Takashi M; Miyake K; Koshikawa T
    Urol Int; 1994; 52(3):140-4. PubMed ID: 8203052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.
    Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Urine examination for tumor cells using quantitative immunocytochemistry. Antibodies to a CEA-like antigen].
    Sautner D; Saeger W
    Fortschr Med; 1995 May; 113(14):207-9. PubMed ID: 7607589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the BTA stat test with voided urine cytology and bladder wash cytology in the diagnosis and monitoring of bladder cancer.
    Leyh H; Marberger M; Conort P; Sternberg C; Pansadoro V; Pagano F; Bassi P; Boccon-Gibod L; Ravery V; Treiber U; Ishak L
    Eur Urol; 1999 Jan; 35(1):52-6. PubMed ID: 9933795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of H-ras mutations in urine sediments complements cytology in the detection of bladder tumors.
    Fitzgerald JM; Ramchurren N; Rieger K; Levesque P; Silverman M; Libertino JA; Summerhayes IC
    J Natl Cancer Inst; 1995 Jan; 87(2):129-33. PubMed ID: 7707384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometry detection and evaluation of bladder tumors.
    Melamed MR
    J Occup Med; 1990 Sep; 32(9):829-33. PubMed ID: 1705974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.
    Huffman JL; Fradet Y; Cordon-Cardo C; Herr HW; Pinsky CM; Oettgen HF; Old LJ; Whitmore WF; Melamed MR
    Cancer Res; 1985 Oct; 45(10):5201-4. PubMed ID: 4027997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.